Journal article

Occult Gastrointestinal Perforation in a Patient With EGFR-Mutant Non–Small-Cell Lung Cancer Receiving Combination Chemotherapy With Atezolizumab and Bevacizumab: Brief Report

A Gunjur, G Chong, A Lim, E Lau, P Mitchell, T John, S Arulananda

Clinical Lung Cancer | CIG MEDIA GROUP, LP | Published : 2020

DOI: 10.1016/j.cllc.2019.11.014

University of Melbourne Researchers

Citation metrics

4Scopus
5Web of Science
5Dimensions

Keywords

Phase-Iii Trial
32 Biomedical and Clinical Sciences
Egfr-Mutant
3211 Oncology and Carcinogenesis
Science & Technology
Gemcitabine
Nsclc
Placebo
Gastro-Oesophageal Perforation
Oncology
Lung
1st-Line Therapy
Sabr
Toxicities
Cancer
Women'S Health
Life Sciences & Biomedicine
Clinical Research
Lung Cancer